WallStreetZenWallStreetZen

NASDAQ: HOOK
Hookipa Pharma Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their HOOK stock forecasts and price targets.

Forecast return on equity

Is HOOK forecast to generate an efficient return?

Company
-49%
Industry
158.69%
Market
89.3%
HOOK's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is HOOK forecast to generate an efficient return on assets?

Company
-27.26%
Industry
40.47%
HOOK is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

HOOK earnings per share forecast

What is HOOK's earnings per share in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$2.60
Avg 2 year Forecast
-$1.56
Avg 3 year Forecast
-$1.25

HOOK revenue growth forecast

How is HOOK forecast to perform vs Biotechnology companies and vs the US market?

Company
32.55%
Industry
56.87%
Market
9.9%
HOOK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HOOK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HOOK vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
HOOK$1.25N/AN/A
COCP$1.49$6.00+302.68%Buy
ALLR$1.00N/AN/A
HOTH$1.13$4.50+298.23%Strong Buy
LEXX$0.85$7.00+724.50%Buy
View Top Biotech Stocks

Hookipa Pharma Stock Forecast FAQ

What is HOOK's earnings growth forecast for 2025-2027?

(NASDAQ: HOOK) Hookipa Pharma's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 9.99%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.31%.

Hookipa Pharma's earnings in 2025 is -$73,313,000.On average, 1 Wall Street analyst forecast HOOK's earnings for 2025 to be -$31,691,761, with the lowest HOOK earnings forecast at -$31,691,761, and the highest HOOK earnings forecast at -$31,691,761. On average, 1 Wall Street analyst forecast HOOK's earnings for 2026 to be -$19,015,057, with the lowest HOOK earnings forecast at -$19,015,057, and the highest HOOK earnings forecast at -$19,015,057.

In 2027, HOOK is forecast to generate -$15,236,424 in earnings, with the lowest earnings forecast at -$15,236,424 and the highest earnings forecast at -$15,236,424.

If you're new to stock investing, here's how to buy Hookipa Pharma stock.

What is HOOK's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: HOOK) forecast ROE is -49%, which is considered weak.

What is HOOK's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: HOOK) Hookipa Pharma's current Earnings Per Share (EPS) is -$5.84. On average, analysts forecast that HOOK's EPS will be -$2.60 for 2025, with the lowest EPS forecast at -$2.60, and the highest EPS forecast at -$2.60. On average, analysts forecast that HOOK's EPS will be -$1.56 for 2026, with the lowest EPS forecast at -$1.56, and the highest EPS forecast at -$1.56. In 2027, HOOK's EPS is forecast to hit -$1.25 (min: -$1.25, max: -$1.25).

What is HOOK's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: HOOK) forecast ROA is -27.26%, which is lower than the forecast US Biotechnology industry average of 40.47%.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.